Results 251 to 260 of about 241,082 (329)

Upregulation of long non-coding RNA SNHG11 promotes apoptosis and its molecular mechanisms in human osteosarcoma U2OS cells. [PDF]

Sci Rep
Dai Z, Sun Y, Maihemuti M, Du J, Jiang R.   +4 more
europepmc   +1 more source

A case of telangiectatic osteosarcoma of the pelvis.

, 1986
Keiji Kiyohara, Ikuko Masuda, Hiroshi Mizuta, Kenji Kubota, Shuji Saho, Toshio Kitagawa, Makoto Naito, Kiyoshi Takahashi   +7 more
openalex   +2 more sources

Comprehensive Osteosarcoma Treatment with Multifunctional Composite Hydrogels Enabling Combined Photothermal Cancer Ablation and Osteoinductive Tissue Regeneration

Small Methods, EarlyView.
This study presents a comprehensive strategy for treating osteosarcoma and promoting bone tissue regeneration using a multifunctional composite hydrogel composed of mineralized fibers with polyphenols. Furthermore, the biomaterial effectively mitigates the degenerative microenvironment including oxidative stress that develops after tumor ablation. This
Hayeon Byun, Taeyeon Hwang, Hyoryong Lee, Yun‐Jung Choi, Dong‐Jae Kim, Eunji Park, Eunhyung Kim, Sukho Park, Heungsoo Shin   +8 more
wiley   +1 more source

Two-sample Mendelian randomization analysis of the causal association between circulating inflammatory proteins and osteosarcoma. [PDF]

Discov Oncol
Tang H, Tang N, Liao Y, Tan T, Xie H, Wang J, Hui X.   +6 more
europepmc   +1 more source

Irradiation of the Resected Bone and Vascularized Fibular Graft in the Limb-Saving Surgery for Osteosarcoma

, 1989
Osamu Inoue, Kunio Ibaraki, Masanori Takeuchi, Takashi Furugen, Yoshisada Shingaki, Masao Nakano   +5 more
openalex   +2 more sources

Nanozymes in Reactive Oxygen Species‐Dependent Diseases: From Design and Preclinical Studies to Clinical Translation Prospects

Small Structures, EarlyView.
Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou, Jingyu Yan, Chenying Cui, Yurong Xu, Kaifang Zhang, Meijun Du, Zhuowei Zhang, Xiuping Wu, Bing Li   +8 more
wiley   +1 more source

Physical Therapy Management of Patients with Osteosarcoma

, 1984

openalex   +1 more source

Plasma POSTN Derived From Bile Proteome Is a Promising Biomarker for Cholangiocarcinoma With Efficacy Comparable and Complementary to CA19.9

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Cholangiocarcinoma presents a global health challenge due to its increasing incidence and poor prognosis, primarily resulting from delayed diagnosis. There is an urgent need for a reliable biomarker to enhance early detection. Materials and Methods Patients with cholangiocarcinoma were enrolled into three cohorts: a discovery set (n 
Lichieh Julie Chu, Chia‐Jung Tsai, Chun‐Chun Chien, Yung‐Chin Hsiao, Jau‐Song Yu, Jun‐Yi Tsai, Ta‐Sen Yeh   +6 more
wiley   +1 more source